J&J seeks bioethics advice on compassionate use of drugs

WASHINGTON (AP) — Dying patients sometimes seek emergency access to experimental medicines, desperate for a last-chance treatment even if there’s little proof it could help. Now drug giant Johnson & Johnson is taking an unusual step, turning to independent bioethicists for advice on when to say yes or no.

Originally posted here: 
J&J seeks bioethics advice on compassionate use of drugs